Last week, federal prosecutors charged a leading government Alzheimer’s researcher with engaging in a criminal conflict of interest. The researcher, working for the National Institute of Health (NIH), had earned $285,000 in private consulting fees from a pharmaceutical giant. The researcher stands accused of performing consulting work for Pfizer Inc. that improperly overlapped with his government duties.
This charge comes after the government announced tougher ethical restrictions on NIH researchers to avoid such conflicts of interest where employees were making significant money from consulting with pharmaceutical firms. If convicted, this researcher faces a maximum of 1 year in prison and a $100,000 fine.
For the full article.